Cell tracking with optical imaging

被引:151
作者
Sutton, Elizabeth J. [1 ]
Henning, Tobias D. [1 ]
Pichler, Bernd J. [4 ]
Bremer, Christoph [2 ,3 ]
Daldrup-Link, Heike E. [1 ]
机构
[1] Univ Calif San Francisco, Dept Radiol, San Francisco, CA 94143 USA
[2] Univ Munster, Dept Radiol, Munster, Germany
[3] Univ Munster, Interdisciplinary Ctr Clin Res FG3, Munster, Germany
[4] Univ Tubingen, Lab Preclin Imaging & Imaging Technol, Werner Siemens Fdn, Dept Radiol, Tubingen, Germany
关键词
optical imaging; cell tracking; fluorescent dyes; near infrared; in vivo; molecular imaging;
D O I
10.1007/s00330-008-0984-z
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
Adaptability, sensitivity, resolution and non-invasiveness are the attributes that have contributed to the longstanding use of light as an investigational tool and form the basis of optical imaging (OI). OI, which encompasses numerous techniques and methods, is rapid (< 5 min), inexpensive, noninvasive, nontoxic (no radiation) and has molecular (single-cell) sensitivity, which is equal to that of conventional nuclear imaging and several orders of magnitude greater than MRI. This article provides a comprehensive overview of emerging applications of OI-based techniques for in vivo monitoring of new stem cell-based therapies. Different fluorochromes for cell labeling, labeling methods and OI-based cell-tracking techniques will be reviewed with respect to their technical principles, current applications and aims for clinical translation. Advantages and limitations of these new OI-based cell-tracking techniques will be discussed. Non-invasive mapping of cells labeled with fluorochromes or OI marker genes has the potential to evolve further within the clinical realm.
引用
收藏
页码:2021 / 2032
页数:12
相关论文
共 69 条
[1]   In vivo imaging platform for tracking immunotherapeutic cells [J].
Ahrens, ET ;
Flores, R ;
Xu, HY ;
Morel, PA .
NATURE BIOTECHNOLOGY, 2005, 23 (08) :983-987
[2]   Transplanted hematopoietic cells seed in clusters in recipient bone marrow in vivo [J].
Askenasy, N ;
Zorina, T ;
Farkas, DL ;
Shalit, I .
STEM CELLS, 2002, 20 (04) :301-310
[3]   Optical imaging of PKH-labeled hematopoietic cells in recipient bone marrow in vivo [J].
Askenasy, N ;
Farkas, DL .
STEM CELLS, 2002, 20 (06) :501-513
[4]   Systemic delivery of bone marrow-derived mesenchymal stem cells to the infarcted myocardium - Feasibility, cell migration, and body distribution [J].
Barbash, IM ;
Chouraqui, P ;
Baron, J ;
Feinberg, MS ;
Etzion, S ;
Tessone, A ;
Miller, L ;
Guetta, E ;
Zipori, D ;
Kedes, LH ;
Kloner, RA ;
Leor, J .
CIRCULATION, 2003, 108 (07) :863-868
[5]  
Becker A, 2000, ANN NY ACAD SCI, V921, P275
[6]   Effects of angiogenesis inhibitors on multistage carcinogenesis in mice [J].
Bergers, G ;
Javaherian, K ;
Lo, KM ;
Folkman, J ;
Hanahan, D .
SCIENCE, 1999, 284 (5415) :808-812
[7]   Optimizing techniques for tracking transplanted stem cells in vivo [J].
Brazelton, TR ;
Blau, HM .
STEM CELLS, 2005, 23 (09) :1251-1265
[8]   Optical imaging of matrix metalloproteinase-2 activity in tumors: Feasibility study in a mouse model [J].
Bremer, C ;
Bredow, S ;
Mahmood, U ;
Weissleder, R ;
Tung, CH .
RADIOLOGY, 2001, 221 (02) :523-529
[9]   Iron oxide MR contrast agents for molecular and cellular imaging [J].
Bulte, JWM ;
Kraitchman, DL .
NMR IN BIOMEDICINE, 2004, 17 (07) :484-499
[10]   In vivo visualization of embryonic stem cell survival, proliferation, and migration after cardiac delivery [J].
Cao, F ;
Lin, S ;
Xie, XY ;
Ray, P ;
Patel, M ;
Zhang, XZ ;
Drukker, M ;
Dylla, SJ ;
Connolly, AJ ;
Chen, XY ;
Weissman, IL ;
Gambhir, SS ;
Wu, JC .
CIRCULATION, 2006, 113 (07) :1005-1014